One patient with lobular carcinoma had two CDH1 mutations and one ERBB2 mutation at ~16% allelic fraction, as well as a distinct set of mutations in PTEN, BRCA2 and PMS2 at ~5% allelic fraction. Here, PMS2 is linked to breast lobular carcinoma.